View older revisions Content changed at 2022-02-25, 1400/12/06

Protocol summary

Study aim
The comparison of treatment with dienogest and contraceptive oral pills on the pain and quality of life in surgery patients with advanced endometriosis
Design
This study will perform before and after the surgical procedure in three groups of patients with advanced endometriosis who will receive dienogest and contraceptive pills after surgery. Participants will be randomly assigned to three groups (two intervention groups and a control group). Sample size will be calculated and applied using the sample size calculation formula
Settings and conduct
Patients with advanced endometriosis undergoing surgery in the pediatric ward of Rasoul Akram Hospital. After surgery, the patients will be divided into three groups: treatment with dienogest and contraceptive pill (LD) and also a control group. Quality of life (WHOQOL-BREF), VAS, and three-point score questionnaires will be used before and in two stages of post-test and follow-up, 3 and 6 months after surgery, respectively, and then will compare between the three groups.
Participants/Inclusion and exclusion criteria
Initial diagnosis of endometriosis and chronic pelvic pain associated with endometriosis in surgery patients, informed consent to study, no pelvic pain originating from other organs
Intervention groups
This study was performed before and after the surgical procedure in three groups of patients with advanced endometriosis who received dienogest (2 mg) and contraceptive pills (LD) and also a placebo for the control group after surgery and compared.
Main outcome variables
Pain and quality of life in advanced endometriosis in surgery patients

General information

Reason for update
Add a control group to study and conduct experiments with three groups Correction of the realized time of the beginning and end of the trial
Acronym
IRCT registration information
IRCT registration number: IRCT20191011045063N1
Registration date: 2020-02-20, 1398/12/01
Registration timing: registered_while_recruiting

Last update: 2022-02-25, 1400/12/06
Update count: 4
Registration date
2020-02-20, 1398/12/01
Registrant information
Name
Gelareh Niakan
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 8807 1886
Email address
g.niakan59@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2019-03-21, 1398/01/01
Expected recruitment end date
2019-11-22, 1398/09/01
Actual recruitment start date
2018-03-27, 1397/01/07
Actual recruitment end date
2020-03-05, 1398/12/15
Trial completion date
2020-03-29, 1399/01/10
Scientific title
The comparison of treatment with dienogest and contraceptive oral pills on the improvement of pain, and quality of life in surgery patients with advanced endometriosis
Public title
The comparison of treatment with dienogest and contraceptive oral pills on the improvement of pain, and quality of life in surgery patients with advanced endometriosis
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Early diagnosis of endometriosis and chronic pelvic pain associated with endometriosis Patients with advanced endometriosis who underwent surgery Age 18 - 45 years Body mass index (BMI) 18.5 – 29.9 kg/m2; No gynecological malignancy No contraindications to OCP or dienogest No plans of pregnancy in the near No underlying diseases
Exclusion criteria:
Personal dissatisfaction for inclusion in the study Patients whose pelvic pain originates from other organs Use of gonadotropins or other hormones three months before surgery
Age
From 18 years old to 45 years old
Gender
Female
Phase
1-2
Groups that have been masked
No information
Sample size
Target sample size: 108
Actual sample size reached: 108
Randomization (investigator's opinion)
Randomized
Randomization description
Using a simple random method to assign participants to three groups. Eligible individuals will be randomly divided into three groups using Excel software and RANDBETWEEN command.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
shahrake gharb
City
Tehran
Province
Tehran
Postal code
1467864184
Approval date
2018-05-05, 1397/02/15
Ethics committee reference number
IR.IUMS.FMD..REC.1398.128

Health conditions studied

1

Description of health condition studied
Advanced endometriosis
ICD-10 code
N80
ICD-10 code description
Endometriosis

Primary outcomes

1

Description
Pain
Timepoint
Before surgery, 3 and 6 months after surgery
Method of measurement
Pelvic pain and dyspareunia scores are evaluated using the Visual Analogue Scale (VAS) and dysuria and dyschezia using a three-point score questionnire by possible answers to the items were “yes”, “no”, and “a little”.

Secondary outcomes

1

Description
Quality of life
Timepoint
Before surgery, 3 and 6 months after surgery
Method of measurement
Quality of life was measured using WHOQOL-BREF

2

Description
Edverse effects of the treatment
Timepoint
3 and 6 months after surgery
Method of measurement
Questionnaire

3

Description
Pain recurrence
Timepoint
6 months after surgery
Method of measurement
Questionnaire

Intervention groups

1

Description
Intervention group: The first group will receive the dienogest drug. Dosage of one tablet of 2 mg daily for six months
Category
Treatment - Drugs

2

Description
Intervention group: The second group will receive contraceptive pills. One tablet daily for six months
Category
Treatment - Drugs

3

Description
Control group: Placebo
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Rasoul Akram hospital
Full name of responsible person
Gelareh Niakan
Street address
No. 7, Falamak shomali Ave.,shahrake gharb
City
Tehran
Province
Tehran
Postal code
1467864184
Phone
+98 21 8807 1886
Email
g.niakan59@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Gelareh Niakan
Street address
Shahrake gharb
City
Tehran
Province
Tehran
Postal code
1467864184
Phone
+98 21 8807 1886
Email
g.niakan59@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
10
Public or private sector
Private
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Persons

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Gelareh Niakan
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Gynecology and Obstetrics
Street address
shahrak gharb
City
Tehran
Province
Tehran
Postal code
147864184
Phone
+98 21 8807 1886
Email
g.niakan59@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Abolfazl Mehdizadeh
Position
professor
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
shahrak gharb
City
Tehran
Province
Tehran
Postal code
1467864184
Phone
+98 21 8807 1886
Email
g.niakan59@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Gelareh Niakan
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Gynecology and Obstetrics
Street address
shahrak gharb
City
tehran
Province
Tehran
Postal code
1467864184
Phone
+98 21 8807 1886
Email
g.niakan59@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
No more information
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
No - There is not a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Loading...